EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Recurrent human 16p11.2 microdeletions in type I Mayer–Rokitansky–Küster–Hauser ( MRKH ) syndrome patients in Chinese Han population

Kaizhen Su, Han Liu iD, Xiaoqun Ye, Hangmei Jin, Zhenwei Xie, Chunbo Yang, Daizhan Zhou, Hefeng Huang, Yanting Wu

Molecular Genetics & Genomic Medicine · 2024

DOI: 10.1002/mgg3.2280 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Genetics & Genomic Medicine, 2024. Verfasst von Kaizhen Su und 8 weiteren Autor:innen. Beteiligte Einrichtung: The International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. Hauptthemen laut MEDLINE: DNA Copy Number Variations, 46, XX Disorders of Sex Development, Congenital Abnormalities. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, CAMS Innovation Fund for Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Backgrounds Mayer‐Rokitansky‐Küster‐Hauser (MRKH) syndrome, a severe congenital malformation of the female genital tract, is a highly heterogeneous disease which has no clear etiology. Previous studies have suggested that copy number variations (CNVs) and single‐gene mutations might contribute to the development of MRKH syndrome. In particular, deletions in 16p11.2, which are suggested to be involved in several congenital diseases, have been reported in Chinese type II MRKH patients and European MRKH patients. However, few CNVs including 16p11.2 microdeletions were identified in Chinese type I MRKH cases although it accounted for the majority of MRKH patients in China. Thus, we conducted a retrospective study to identify whether CNVs at human chromosome 16p11.2 are risk factors of type I MRKH syndrome in the Chinese Han population.

Methods

We recruited 143 patients diagnosed with type I MRKH between 2012 and 2014. Five hundred unrelated Chinese without congenital malformation were enrolled in control group, consisting of 197 from the 1000 Genomes Project and 303 from Fudan University. Quantitative PCR, array comparative genomic hybridization, and sanger sequencing were conducted to screen and verify candidate variant.

Results

Our study identified recurrent 16p11.2 microdeletions of approximately 600 kb in two out of the 143 type I MRKH syndrome patients using high‐density array‐based comparative genomic hybridization (aCGH), while no 16p11.2 deletion was found in the control group. We did not find any mutations in TBX6 gene in our samples.

Conclusions

The results of the study identify 16p11.2 deletion in Chinese MRKH I patients for the first time, as well as support the contention that 16p11.2 microdeletions are associated with MRKH syndrome in both types across populations. It is suggested that 16p11.2 microdeletions should be included in molecular diagnosis and genetic counseling of female reproductive tract disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA Copy Number Variations46, XX Disorders of Sex DevelopmentCongenital AbnormalitiesHumansFemaleRetrospective StudiesComparative Genomic HybridizationT-Box Domain ProteinsMullerian Ducts

Stichwörter der Autor:innen

16p11.2 deletionChinese Han populationMRKH syndromecopy number variant

Substanzen

TBX6 protein, humanT-Box Domain Proteins

Autor:innen und Institutionen

  • The International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
  • Shanghai Municipal Key Clinical Specialty, Shanghai, China.
  • Women's Hospital, School of Medicine, Zhejiang University, Zhejiang, China.
  • Bio-X Institutes of Shanghai Jiao Tong University, Shanghai, China.
  • Obstetrics and Gynecology Hospital, Institute of Reproduction and Development, Fudan University, Shanghai, China.
  • Research Units of Embryo Original Diseases, Chinese Academy of Medical Sciences (No. 2019RU056), Shanghai, China.

ORCID-Profile: Han Liu

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • CAMS Innovation Fund for Medical Sciences
  • Program of Shanghai Academic Research Leader
  • Natural Science Foundation of Shanghai
  • Shanghai Clinical Research Center for Gynecological Diseases
  • Shanghai Urogenital System Diseases Research Center
  • Shanghai Frontiers Science Research Base of Reproduction and Development

Zitieren

APA

Su, K., Liu, H., Ye, X., Jin, H., Xie, Z., Yang, C., Zhou, D., Huang, H., & Wu, Y. (2024). Recurrent human 16p11.2 microdeletions in type I Mayer–Rokitansky–Küster–Hauser ( MRKH ) syndrome patients in Chinese Han population. Molecular Genetics & Genomic Medicine. https://doi.org/10.1002/mgg3.2280

Vancouver

Su K, Liu H, Ye X, Jin H, Xie Z, Yang C, et al. Recurrent human 16p11.2 microdeletions in type I Mayer–Rokitansky–Küster–Hauser ( MRKH ) syndrome patients in Chinese Han population. Molecular Genetics & Genomic Medicine. 2024. doi:10.1002/mgg3.2280

BibTeX
@article{Su2024,
  author = {Su, Kaizhen and Liu, Han and Ye, Xiaoqun and Jin, Hangmei and Xie, Zhenwei and Yang, Chunbo and Zhou, Daizhan and Huang, Hefeng and Wu, Yanting},
  title = {Recurrent human 16p11.2 microdeletions in type I Mayer–Rokitansky–Küster–Hauser ( MRKH ) syndrome patients in Chinese Han population},
  journal = {Molecular Genetics & Genomic Medicine},
  year = {2024},
  doi = {10.1002/mgg3.2280}
}
Kostenlos starten →